Biotronik, Inc.   Report issue

For profit Phase 4
Founded: Berlin Germany (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2008
NCT00559988
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Biotronik AG | Biotronik, Inc. | Biotronik Japan, Inc. | Biotronik Korea Co., Ltd | Biotronik SE & Co. KG

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Atrial Flutter (Phase 4)

Embolism (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6